These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 23691059)

  • 1. Mice transgenic for CD4-specific human CD4, CCR5 and cyclin T1 expression: a new model for investigating HIV-1 transmission and treatment efficacy.
    Seay K; Qi X; Zheng JH; Zhang C; Chen K; Dutta M; Deneroff K; Ochsenbauer C; Kappes JC; Littman DR; Goldstein H
    PLoS One; 2013; 8(5):e63537. PubMed ID: 23691059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-Throughput Humanized Mouse Models for Evaluation of HIV-1 Therapeutics and Pathogenesis.
    Thomas T; Seay K; Zheng JH; Zhang C; Ochsenbauer C; Kappes JC; Goldstein H
    Methods Mol Biol; 2016; 1354():221-35. PubMed ID: 26714715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Vaginal Acquisition and Dissemination of HIV-1 Infection in a Novel Transgenic Mouse Model Is Facilitated by Coinfection with Herpes Simplex Virus 2 and Is Inhibited by Microbicide Treatment.
    Seay K; Khajoueinejad N; Zheng JH; Kiser P; Ochsenbauer C; Kappes JC; Herold B; Goldstein H
    J Virol; 2015 Sep; 89(18):9559-70. PubMed ID: 26157126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progress toward a human CD4/CCR5 transgenic rat model for de novo infection by human immunodeficiency virus type 1.
    Keppler OT; Welte FJ; Ngo TA; Chin PS; Patton KS; Tsou CL; Abbey NW; Sharkey ME; Grant RM; You Y; Scarborough JD; Ellmeier W; Littman DR; Stevenson M; Charo IF; Herndier BG; Speck RF; Goldsmith MA
    J Exp Med; 2002 Mar; 195(6):719-36. PubMed ID: 11901198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mice transgenic for human CD4 and CCR5 are susceptible to HIV infection.
    Browning J; Horner JW; Pettoello-Mantovani M; Raker C; Yurasov S; DePinho RA; Goldstein H
    Proc Natl Acad Sci U S A; 1997 Dec; 94(26):14637-41. PubMed ID: 9405665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary T-cells from human CD4/CCR5-transgenic rats support all early steps of HIV-1 replication including integration, but display impaired viral gene expression.
    Goffinet C; Michel N; Allespach I; Tervo HM; Hermann V; Kräusslich HG; Greene WC; Keppler OT
    Retrovirology; 2007 Jul; 4():53. PubMed ID: 17655755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A recombinant vesicular stomatitis virus encoding CCR5-tropic HIV-1 receptors targets HIV-1-infected cells and controls HIV-1 infection.
    Okuma K; Fukagawa K; Kohma T; Takahama Y; Hamaguchi Y; Ito M; Tanaka Y; Buonocore L; Rose JK; Hamaguchi I
    Microbes Infect; 2017; 19(4-5):277-287. PubMed ID: 28025070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment of mouse leukemia cell lines expressing human CD4/CCR5 using lentiviral vectors.
    Li YJ; ZhuGe FY; Zeng CC; He JY; Tan N; Liang J
    Virus Genes; 2017 Apr; 53(2):197-204. PubMed ID: 28028680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relief of preintegration inhibition and characterization of additional blocks for HIV replication in primary mouse T cells.
    Zhang JX; Diehl GE; Littman DR
    PLoS One; 2008 Apr; 3(4):e2035. PubMed ID: 18446227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HSV type 2 infection increases HIV DNA detection in vaginal tissue of mice expressing human CD4 and CCR5.
    Zariffard MR; Saifuddin M; Finnegan A; Spear GT
    AIDS Res Hum Retroviruses; 2009 Nov; 25(11):1157-64. PubMed ID: 19886831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV-1 R5 Macrophage-Tropic Envelope Glycoprotein Trimers Bind CD4 with High Affinity, while the CD4 Binding Site on Non-macrophage-tropic, T-Tropic R5 Envelopes Is Occluded.
    Quitadamo B; Peters PJ; Repik A; O'Connell O; Mou Z; Koch M; Somasundaran M; Brody R; Luzuriaga K; Wallace A; Wang S; Lu S; McCauley S; Luban J; Duenas-Decamp M; Gonzalez-Perez MP; Clapham PR
    J Virol; 2018 Jan; 92(2):. PubMed ID: 29118121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycosylphosphatidylinositol-Anchored Anti-HIV scFv Efficiently Protects CD4 T Cells from HIV-1 Infection and Deletion in hu-PBL Mice.
    Ye C; Wang W; Cheng L; Li G; Wen M; Wang Q; Zhang Q; Li D; Zhou P; Su L
    J Virol; 2017 Feb; 91(3):. PubMed ID: 27881659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct HIV-1 entry phenotypes are associated with transmission, subtype specificity, and resistance to broadly neutralizing antibodies.
    Chikere K; Webb NE; Chou T; Borm K; Sterjovski J; Gorry PR; Lee B
    Retrovirology; 2014 Jun; 11():48. PubMed ID: 24957778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T-cell protection and enrichment through lentiviral CCR5 intrabody gene delivery.
    Swan CH; Bühler B; Steinberger P; Tschan MP; Barbas CF; Torbett BE
    Gene Ther; 2006 Oct; 13(20):1480-92. PubMed ID: 16738691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD4-specific transgenic expression of human cyclin T1 markedly increases human immunodeficiency virus type 1 (HIV-1) production by CD4+ T lymphocytes and myeloid cells in mice transgenic for a provirus encoding a monocyte-tropic HIV-1 isolate.
    Sun J; Soos T; Kewalramani VN; Osiecki K; Zheng JH; Falkin L; Santambrogio L; Littman DR; Goldstein H
    J Virol; 2006 Feb; 80(4):1850-62. PubMed ID: 16439541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transmitted/founder and chronic subtype C HIV-1 use CD4 and CCR5 receptors with equal efficiency and are not inhibited by blocking the integrin α4β7.
    Parrish NF; Wilen CB; Banks LB; Iyer SS; Pfaff JM; Salazar-Gonzalez JF; Salazar MG; Decker JM; Parrish EH; Berg A; Hopper J; Hora B; Kumar A; Mahlokozera T; Yuan S; Coleman C; Vermeulen M; Ding H; Ochsenbauer C; Tilton JC; Permar SR; Kappes JC; Betts MR; Busch MP; Gao F; Montefiori D; Haynes BF; Shaw GM; Hahn BH; Doms RW
    PLoS Pathog; 2012; 8(5):e1002686. PubMed ID: 22693444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for a post-entry barrier to R5 HIV-1 infection of CD4 memory T cells.
    Vyakarnam A; Eyeson J; Teo I; Zuckerman M; Babaahmady K; Schuitemaker H; Shaunak S; Rostron T; Rowland-Jones S; Simmons G; Clapham P
    AIDS; 2001 Sep; 15(13):1613-26. PubMed ID: 11546935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human cyclin T1 expression ameliorates a T-cell-specific transcriptional limitation for HIV in transgenic rats, but is not sufficient for a spreading infection of prototypic R5 HIV-1 strains ex vivo.
    Michel N; Goffinet C; Ganter K; Allespach I; Kewalramani VN; Saifuddin M; Littman DR; Greene WC; Goldsmith MA; Keppler OT
    Retrovirology; 2009 Jan; 6():2. PubMed ID: 19144136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced CD4+ cellular apoptosis by CCR5-restricted HIV-1 envelope glycoprotein variants from patients with progressive HIV-1 infection.
    Wade J; Sterjovski J; Gray L; Roche M; Chiavaroli L; Ellett A; Jakobsen MR; Cowley D; Pereira Cda F; Saksena N; Wang B; Purcell DF; Karlsson I; Fenyö EM; Churchill M; Gorry PR
    Virology; 2010 Jan; 396(2):246-55. PubMed ID: 19913863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. G protein-dependent CCR5 signaling is not required for efficient infection of primary T lymphocytes and macrophages by R5 human immunodeficiency virus type 1 isolates.
    Amara A; Vidy A; Boulla G; Mollier K; Garcia-Perez J; Alcamí J; Blanpain C; Parmentier M; Virelizier JL; Charneau P; Arenzana-Seisdedos F
    J Virol; 2003 Feb; 77(4):2550-8. PubMed ID: 12551993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.